KDM6A and neoplasm: On the other hand, a piRNA derived from a tumor-suppressive lncRNA and PIWIL1/4 recruit histone-modifying enzymes MLL3 and UTX (or KDM6A) to activate the transcription of TRAIL (TNF-related apoptosis-inducing ligand) leading to tumor growth inhibition [47].